MedPath

Evaluation of the effects of vitamin D on left ventricular function and function class of patients with heart failure

Phase 3
Conditions
Heart Failure.
Heart failure
Registration Number
IRCT138706121181N1
Lead Sponsor
Isfahan University of medical sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Inclusion: ambulatory New York Heart Association (NYHA) Functional Class = III; LV ejection fraction (LVEF) = 45%. Exclusion: hypercalcemia; nephrolithiasis; intake of supplements containing vitamin D or calcium; therapy with corticosteroids or anticonvulsants; serum creatinine concentration > 2mg/dl.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
eft ventricular ejection fraction (LVEF). Timepoint: six months. Method of measurement: Echocardiography.;Changes in Left ventricular ejection fraction. Timepoint: 6 months. Method of measurement: echocardiography.
Secondary Outcome Measures
NameTimeMethod
YHA function class. Timepoint: six months. Method of measurement: clinical interview.
© Copyright 2025. All Rights Reserved by MedPath